BioXcel Therapeutics
BTAI
BTAI
116 hedge funds and large institutions have $475M invested in BioXcel Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 51 increasing their positions, 32 reducing their positions, and 19 closing their positions.
Holders
116
Holders Change
-1
Holders Change %
-0.85%
% of All Funds
2.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
51
Reduced
32
Closed
19
Calls
$11.3M
Puts
$10.5M
Net Calls
+$828K
Net Calls Change
-$16.2M
Top Buyers
| 1 |
FLAM
1
First Light Asset Management
Edina,
Minnesota
|
$15.5M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$96.2M |
| 3 |
3
BlackRock
New York
|
$45.5M |
| 4 |
4
Two Sigma Investments
New York
|
$6.45M |
| 5 |
5
AllianceBernstein
Nashville,
Tennessee
|
$35.2M |
